Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak

JAMA Intern Med. 2017 Jan 1;177(1):21-23. doi: 10.1001/jamainternmed.2016.7585.

Authors

Rita F Redberg¹, Mitchell H Katz²

Affiliations

¹ Department of Medicine, University of California, San Francisco2Editor, JAMA Internal Medicine.
² County of Los Angeles, Department of Health Services, Los Angeles, California4Deputy Editor, JAMA Internal Medicine.

PMID: 27838697
DOI: 10.1001/jamainternmed.2016.7585

No abstract available

Publication types

Editorial

MeSH terms

Adult
Aged
Cardiovascular Diseases / prevention & control*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Internal Medicine*
Middle Aged
Periodicals as Topic*
Primary Prevention / methods*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors